This was confirmed by Ki67 staining of sections from mammary tumours across the cohorts (considering only adenocarcinomas to eliminate different tumour histotypes as a potential confounding factor) (Fig. 2E; Table S4). This evidence concerns the gene MKI67 and breast cancer.